Company Analysis

Equillium, Inc. (EQ)

Nasdaq: EQ · Pharmaceutical Preparations · La Jolla, CA · filing with the SEC since 2018
Grade5.9
◀ Past 5.1● Present 5.9▶ Future 6.7
3 est.

Who runs Equillium, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Steel Bruce D.
Chief Executive Officer. First filing Oct 2018, latest Jan 9, 2026, 0 filings in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
16 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Connelly StephenPresident and CSOOct 2018Jun 5, 20262 · $700,000
Zedelmayer ChristineSr. Vice President and COOJan 2020Jun 5, 202616 · $1.8M
Bradbury DanielCHAIRMANOct 2018May 29, 2026none
Tom PennyPrincipal Accounting OfficerMar 2024May 29, 20262 · $200,000
Steel Bruce D.Chief Executive OfficerOct 2018Jan 9, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Demski Martha JdirectorOct 2018May 29, 2026none
Mcdermott Charles DouglasdirectorOct 2018May 29, 2026none
Pruzanski MarkdirectorOct 2018May 29, 2026none
Troupin BarbaradirectorMar 2022May 29, 2026none
Earlier names on the record11, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton EQ · research, not advice